Spero Therapeutics

Spero Therapeutics develops oral and IV antibiotics for MDR bacterial infections and rare diseases.

Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2017
Stage of Initial Investment
Series C
Initial Investment Year
2017